Study Evaluating the Safety and Tolerability of L-377202
NCT00987753
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
13
Enrollment
OTHER
Sponsor class
Conditions
Hormone Refractory Prostate Cancer
Prostate Cancer
Interventions
DRUG:
L-377202
Sponsor
University of Alabama at Birmingham
Collaborators
[object Object]